Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Brain Behav Immun. 2009 Dec 2;24(3):444–450. doi: 10.1016/j.bbi.2009.11.017

Table 1.

Descriptive information about sample

Asthma Healthy
% M SD % M SD
Age (range 10-20 yearsa) 15.0 2.8 15.9 2.0
Gender (% male) 68 57
Ethnicity
            Caucasian 58
            Asian 26 17
            Other 16 9
Severity
            Mild intermittent 13
            Mild persistent 45
            Moderate persistent 29
            Severe 13
Atopic 55 13
FEV1/FVC .76 .12 .84 .08
ICSa 6.0 6.3 0 0
ICS dose
            Low 73
            Medium 27
            High 0
Beta agonistsb 5.1 6.2 0 0
Baseline FEV1% 90.6 16.6 99.0 8.4
Post-task FEV1% 90.0 14.1 97.0 9.1
Baseline FeNO (ppb) 58.5 57.5 22.8 24.4
Post-task FeNO (ppb) 53.5 51.5 21.4 23.5

ICS=inhaled corticosteroids. FEV1%= forced expiratory volume in 1 second percent predicted. FeNO= fractional concentration of exhaled nitric oxide in parts per billion. FEV1/FVC=ratio of FEV1 to forced vital capacity.

a

age range for asthma group: 10-20 years; age range for healthy group: 11-18 years.

b

=number of days taken in previous 2 weeks, range for both medications in the asthma group was from 0 to 14 days.